مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

541
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

135
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

SINGLE-CENTER EXPERIENCE WITH CYCLOSPORINE FOR TREATMENT OF IDIOPATHIC MINIMAL CHANGE NEPHROTIC SYN-DROME IN CHILDREN

Pages

  127-135

Abstract

 Introduction: CYCLOSPORINE A is used in the treatment of idiopathic nephrotic syndrome. We conducted this study to evaluate the effect of CYCLOSPORINE and its combination with KETOCONAZOLE in Egyptian nephrotic CHILDren with steroid-resistant and steroid-dependant minimal change.Materials and Methods: Forty-eight CHILDren with minimal change lesions who received CYCLOSPORINE with or without KETOCONAZOLE were studied. Their mean age was 5.17±1.59 years, and they were 31 boys and 17 girls. The mean duration of the disease was 6.22 ± 3.16 years. Thirty-one of the CHILDren were steroid dependent and 17 were steroid resistant. CYCLOSPORINE treatment was commenced after remission was attained and adjusted to a target trough level of 100 ng/mL. The mean CYCLOSPORINE therapy at a dose of 2.07 ± 0.91 mg/kg was administered for a mean of 25.75 ± 1.95 months. Thirty-three patients received adjunctive KETOCONAZOLE therapy.Results: Thirty-eight patients (79.2%) responded well to CYCLOSPORINE. Steroid therapy could be discontinued in 43 patients (89.6%), but 9 experienced relapse. Ten patients (20.8%) were resistant to CYCLOSPORINE therapy. Fifteen patients received CYCLOSPORINE alone, while 33 received concomitant CYCLOSPORINE and KETOCONAZOLE. The response to CYCLOSPORINE was significantly better in those on KETOCONAZOLE. The economic effect of KETOCONAZOLE therapy was a reduction in the costs of CYCLOSPORINE treatment by 47.4% at 1 year of treatment.Conclusions: CYCLOSPORINE treatment in CHILDren with minimal change nephrotic syndrome is effective in preventing relapse and decreasing steroid toxicity. Its combination with low-dose KETOCONAZOLE is safe, reduces treatment costs, and improves the response to CYCLOSPORINE.

Cites

  • No record.

    • References

    Cite

    APA: Copy

    SABRY, A., EL HUSSEINI, A., EL DAHSHAN, KH., & SOBH, M.. (2009). SINGLE-CENTER EXPERIENCE WITH CYCLOSPORINE FOR TREATMENT OF IDIOPATHIC MINIMAL CHANGE NEPHROTIC SYN-DROME IN CHILDREN. IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD), 3(3), 127-135. SID. https://sid.ir/paper/308745/en

    Vancouver: Copy

    SABRY A., EL HUSSEINI A., EL DAHSHAN KH., SOBH M.. SINGLE-CENTER EXPERIENCE WITH CYCLOSPORINE FOR TREATMENT OF IDIOPATHIC MINIMAL CHANGE NEPHROTIC SYN-DROME IN CHILDREN. IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD)[Internet]. 2009;3(3):127-135. Available from: https://sid.ir/paper/308745/en

    IEEE: Copy

    A. SABRY, A. EL HUSSEINI, KH. EL DAHSHAN, and M. SOBH, “SINGLE-CENTER EXPERIENCE WITH CYCLOSPORINE FOR TREATMENT OF IDIOPATHIC MINIMAL CHANGE NEPHROTIC SYN-DROME IN CHILDREN,” IRANIAN JOURNAL OF KIDNEY DISEASES (IJKD), vol. 3, no. 3, pp. 127–135, 2009, [Online]. Available: https://sid.ir/paper/308745/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button